1) HIV is a virus that destroys CD4 immune cells, leading to AIDS if left untreated. With medication, a person can live with HIV for decades without progressing to AIDS.
2) HIV was first observed in 1981 and is believed to have originated from chimpanzees in West Africa. It is transmitted through sexual contact, blood, and from mother to child.
3) Over 42 million people worldwide are currently living with HIV. While treatments have increased life expectancy, aging poses new health challenges for those with HIV due to increased risk of conditions like dementia, heart disease, and infections.
HIV infection
Mode of transmission, pathogenesis, clinical manifestations, laboratory diagnosis, treatment, prevention, prognosis, scope of AIDS vaccine.
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
HIV infection
Mode of transmission, pathogenesis, clinical manifestations, laboratory diagnosis, treatment, prevention, prognosis, scope of AIDS vaccine.
At the end of the session, the students shall be able to
Describe the HIV AIDS introduction, epidemiology of HIV AIDS, diagnosis of HIV AIDS, treatment of HIV AIDS and prevention control of HIV AIDS.
HIV AIDS Lecture Presented by me in my Community Dentistry Class, BIBI ASIFA DENTAL COLLEGE, SHAHEED MOHTARMA BENAZIR BHUTTO MEDICAL UNIVERSITY LARKANA, SINDH, PAKISTAN.
HIV (Human Immunodeficiency Virus) infects cells of the immune system and destroys or impairs their function.
Infection ď progressive deterioration of the immune systemď breaking down the body's ability to fight out infections & diseases by opportunistic bacteria, viruses and fungi.
AIDS (Acquired Immune Deficiency Syndrome) refers to the most advanced stages of HIV infection and a collection of signs and symptoms caused by more than 20 opportunistic infections or related cancers.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizensâ Health", on 5 March 2014, Athens, Greece.
Description about recent outbreak of Ebola virus in West African countries with history, pathogenesis, clinical signs and prevention measures of Filoviruses are presented in comprehensive manner.
Monkeypox is a rare zoonosis caused by monkeypox virus. This disease is similar to smallpox disease but with lesser severity. This disease is common among Africans. It can be prevented by avoiding contact with contaminated animal and human fluids as well as respiratory droplets. It require a multidisciplinary approach to achieve cure and prevention.
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).
Monkeypox is a zoonotic disease endemic in the Democratic Republic of Congo (DRC) but prevalent also in other countries of Central and Western Africa. The clinical presentation of monkeypox closely resembles the one of smallpox. The mortality rate is officially about 11% however rates as high as 17% have been observed. The disease has been considered rare and not much attention is paid to it. Nonetheless, the incidence of monkeypox increased 20-fold from 1981-1986 to 2005-2007 (two active surveillance programs). More research, surveillance and effective interventions are needed to ensure it would not gain the potential to become the next global pandemic.
HIV AIDS Lecture Presented by me in my Community Dentistry Class, BIBI ASIFA DENTAL COLLEGE, SHAHEED MOHTARMA BENAZIR BHUTTO MEDICAL UNIVERSITY LARKANA, SINDH, PAKISTAN.
HIV (Human Immunodeficiency Virus) infects cells of the immune system and destroys or impairs their function.
Infection ď progressive deterioration of the immune systemď breaking down the body's ability to fight out infections & diseases by opportunistic bacteria, viruses and fungi.
AIDS (Acquired Immune Deficiency Syndrome) refers to the most advanced stages of HIV infection and a collection of signs and symptoms caused by more than 20 opportunistic infections or related cancers.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizensâ Health", on 5 March 2014, Athens, Greece.
Description about recent outbreak of Ebola virus in West African countries with history, pathogenesis, clinical signs and prevention measures of Filoviruses are presented in comprehensive manner.
Monkeypox is a rare zoonosis caused by monkeypox virus. This disease is similar to smallpox disease but with lesser severity. This disease is common among Africans. It can be prevented by avoiding contact with contaminated animal and human fluids as well as respiratory droplets. It require a multidisciplinary approach to achieve cure and prevention.
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).
Monkeypox is a zoonotic disease endemic in the Democratic Republic of Congo (DRC) but prevalent also in other countries of Central and Western Africa. The clinical presentation of monkeypox closely resembles the one of smallpox. The mortality rate is officially about 11% however rates as high as 17% have been observed. The disease has been considered rare and not much attention is paid to it. Nonetheless, the incidence of monkeypox increased 20-fold from 1981-1986 to 2005-2007 (two active surveillance programs). More research, surveillance and effective interventions are needed to ensure it would not gain the potential to become the next global pandemic.
This is an informative, illustrated presentation about the causes, symptoms, treatment and prevention of HIV AIDS. Gives relevant data, facts and statistics about the disease updated to the most recent 2010 data.
Ellington, Katherine. âInvisible Hope: HIV/AIDS and Womenâ in ed. Grace Bantebya-Kyomuhendo. Womenâs Health: African and Global Perspectives. Kampala: Women and Gender Studies, Makerere University, 2005.
Adult HIV was developed by doctors and nurses with wide experience in the care of adults with HIV, under the auspices of the Desmond Tutu HIV Foundation at the University of Cape Town. It covers: introduction to HIV infection, management of HIV-infected adults at primary-care clinics, preparing patients for antiretroviral (ARV) treatment, ARV drugs, starting and maintaining patients on ARV treatment, opportunistic infections
Adult HIV was developed by doctors and nurses with wide experience in the care of adults with HIV, under the auspices of the Desmond Tutu HIV Foundation at the University of Cape Town. It covers: introduction to HIV infection, management of HIV-infected adults at primary-care clinics, preparing patients for antiretroviral (ARV) treatment, ARV drugs, starting and maintaining patients on ARV treatment, opportunistic infections
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Â
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Â
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Tom Selleck Health: A Comprehensive Look at the Iconic Actorâs Wellness Journeygreendigital
Â
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on:Â Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Â
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
Â
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganongâs Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Â
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowmanâs Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: Whatâs the Latest in Cervical Cancer?bkling
Â
Are you curious about whatâs new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Womenâs Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
Â
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMENâS HEALTH: FERTILITY PRESERVATION
- WHATâS NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
Â
RESULTS: Overall life span (LS) was 2252.1Âą1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years â 64.8%, 20 years â 42.5%. 513 LCP lived more than 5 years (LS=3124.6Âą1525.6 days), 148 LCP â more than 10 years (LS=5054.4Âą1504.1 days).199 LCP died because of LC (LS=562.7Âą374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0âN12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0âN12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. HIV vs. AIDS
Myth vs. Reality
Myth: Having HIV Means You Have AIDS
Reality: Human immunodeficiency virus (HIV) is a virus that destroys
the body's CD4 immune cells, which help fight disease. With the
right medications, you can have HIV for years or decades without
HIV progressing to AIDS. AIDS (acquired immunodeficiency
syndrome) is diagnosed when you have HIV as well as certain
opportunistic infections or your CD4 cell count drops below 200.
4. ⢠HIV is a member of the genus Lentivirus, part of the family Retroviridae.
⢠Transmitted as single-stranded, positive-sense, enveloped RNA viruses.
⢠Upon entry into the target cell, the viral RNA genome is converted (reverse
transcribed) into double-stranded DNA by a virally encoded reverse
transcriptase that is transported along with the viral genome in the virus
particle. The resulting viral DNA is then imported into the cell nucleus and
integrated into the cellular DNA by a virally encoded integrase and host
co-factors.
⢠Two genetically different forms of HIV have been isolated from AIDS
patients. HIV-1 and HIV-2.
HIV-1 is the more common type associated with AIDS in the U.S., Europe &
Central Africa; whereas HIV-2 causes a similar diseas mainly in West
Africa.
* Tests for HIV-2 are also available, and is also routinely screened for in
blood transfusions.
5.
6. History â A rose by any other
name⢠AIDS was first clinically observed in 1981 in the United States.The initial cases
were a cluster of injection drug users and gay men with no known cause of
impaired immunity who showed symptoms of Pneumocystic carinii pneumonia
(PCP), a rare opportunistic infection that was known to occur in people with very
compromised immune systems.Soon after, additional gay men developed a
previously rare skin cancer Kaposi's sarcoma .Many more cases of PCP and KS
emerged, alerting U.S. Centers for Disease Control and Prevention (CDC) and a CDC
task force was formed to monitor the outbreak.
⢠In the beginning, the CDC did not have an official name for the disease, often
referring to it by way of the diseases that were associated with it, for
example, lymphadenopathy, the disease after which the discoverers of HIV
originally named the virus. In the general press, the term GRID, which stood
for Gay-Related Immune Deficiency, had been coined.
⢠The CDC, in search of a name, and looking at the infected communities coined
âthe 4H disease, â as it seemed to single out Haitians, homosexuals, hemophiliacs,
and heroin users.
⢠However, after determining that AIDS was not isolated to the gay community, it
was realized that the term GRID was misleading and AIDS was introduced at a
meeting in July 1982. By September of that year the CDC started using the name
AIDS.
7. Discovery of HIV
⢠In 1983, two separate research groups led by Robert Gallo and Luc
Montagnier independently declared that a novel retrovirus may
have been infecting AIDS patients, and published their findings in
the same issue of the journal âScienceâ. Gallo claimed that a virus
his group had isolated from an AIDS patient was strikingly similar
in shape to other human T-lymphotropic viruses (HTLVs) his group
had been the first to isolate. Gallo's group called their newly
isolated virus HTLV-III. At the same time, Montagnier's group
isolated a virus from a patient presenting with swelling of the lymph
nodes of the neck and physical weakness, two classic symptoms of
AIDS. Contradicting the report from Gallo's group, Montagnier and
his colleagues showed that core proteins of this virus were
immunologically different from those of HTLV-I. Montagnier's
group named their isolated virus lymphadenopathy-associated
virus (LAV). As these two viruses turned out to be the same, in
1986, LAV and HTLV-III were renamed HIV.
8. Origins
⢠Both HIV-1 and HIV-2 are believed to have originated in non-
human primates in West-central Africa and to have transferred to humans in
the early 20th century. HIV-1 appears to have originated in
southern Cameroon through the evolution of SIV, a simian immunodeficiency
virus that infects wild chimpanzee. The closest relative of HIV-2 is SIV (smm), a
virus of the sooty mangabey, an old world monkey living in West Africa (from
southern Senegal to western CĂ´te d'Ivoire).
*New World monkeys such as the owl monkey are resistant to HIV-1
infection (Currently the focus of genetics based studies).
* There is evidence that humans who participate in âbushmeat activitiesâ,
either as hunters or as bushmeat vendors, commonly acquire SIV. However,
SIV is a weak virus, and it is typically suppressed by the human immune
system within weeks of infection. It is thought that several transmissions of
the virus from individual to individual in quick succession are necessary to
allow it enough time to mutate into HIV. Furthermore, due to its relatively low
person-to-person transmission rate (R0: 2-5 via sexual transmission route), it
can only spread throughout the population in the presence of one or more of
high-risk transmission channels, which are thought to have been absent in
Africa prior to the 20th century.
9. Origins (continued)
⢠Genetic studies of the virus suggest that the most recent common ancestor of the
HIV-1 group dates back to around 1910. Proponents of this dating link the HIV
epidemic with the emergence of colonialism and growth of large colonial African
cities, leading to social changes, including a higher degree of sexual promiscuity,
the spread of prostitution, and the concomitant high frequency of genital ulcer
diseases (such as syphilis) in colonial cities. While transmission rates of HIV during
vaginal intercourse are low under regular circumstances they are increased many
fold if one of the partners suffers from a sexually transmitted infection resulting in
genital ulcers. Early 1900s colonial cities were notable due to their high prevalence
of prostitution and genital ulcers to the degree that as of 1928 as many as 45% of
female residents of eastern Kinshasa were thought to have been prostitutes and as
of 1933 around 15% of all residents of the same city were infected by one of the
forms of syphilis.
⢠An alternative view holds that unsafe medical practices in Africa during years
following World War II, such as unsterile reuse of single use syringes during mass
vaccination, antibiotic and anti-malaria treatment campaigns, were the initial
vector that allowed the virus to adapt to humans and spread.
10.
11. Epidemiology
⢠Transmission of HIV occurs under conditions
that facilitate the exchange of blood or body
fluids containing the virus, or virus infected
cells.
The major routes of infection are
1) Sexual contact
2) Parenteral inoculation
3) Vertical transmission (mother to newborn)
12. Epidemiologic studies in the U.S. have identified 4 groups at risk for
developing AIDS. These following distributions are in the US, but are
similar in other countries (except where indicated otherwise)
⢠Homosexual or bisexual males constitute the largest group of infected individuals,
accounting for 48% of reported cases between 2001 â 2004 and 56% of infected
men (4% of which also inject drugs). However, transmission of AIDS in this
category is declining.
⢠Heterosexual contacts of members of other high-risk groups = 34% of infections.
In Africa and Asia, this is by far the largest group of new infections, and the
majority of new cases are in women infected by male partners.
⢠IV drug abusers with no history of sexuality = 17% of all patients
⢠Recepients of blood & blood components who received transfusions of HIV
infected whole blood or blood components = < 1% *including Hemophiliacs who
received factor concentrated before 1985
⢠The epidemiology of HIV infection and AIDS is quite different in children. About 1%
of all AIDS occurs in this population, and about 90% of these cases are the result of
vertical transmission.
13. Added Statistics
⢠Worldwide, more than 22 million people have died of AIDS since
the epidemic was recognized in 1981
⢠About 42 million people are living with the disease, and there are
an estimated 5 million infections each year.
⢠Worldwide, 95% of HIV infections are in developing countries, with
Africa alone carrying more than 50% of the HIV burden. However,
the most rapid increase in HIV infections in the past decade are in
southeast asian countries including Thailand, India, and Indonesia.
⢠The statistics in industrialized nations are only slightly better. For
example, approximately 1 million US citizens are infected (about 1
in every 500 !!) More Americans have dies of aids (>500,000) than
did in both world wars combined.
⢠Although AIDS-related death rates continue to decline from a 1995
peak, AIDS is still the 5th most common cause of death in adults
between the ages of 25 â 44.
14. Aging: The New Challenge
⢠At the start of the epidemic, people who were diagnosed with HIV/AIDS
could expect to live only 1-2 years after that diagnosis. This meant that
the issues of aging were not a major focus for people with HIV disease.
⢠But new medications and treatments have changed that. Life expectancy
for people with HIV disease has increased dramaticallyâwhich means that
they now have to face the challenges of aging with HIV/AIDS.
⢠Normal aging is associated with risks for many different conditions, from
osteoporosis to heart disease, but having HIV can increase those risks.
Some illnesses or conditions which can be worsened by aging and HIV (or
treatments for it) include:
⢠Dementia
⢠Depression
⢠Insulin resistance
⢠High cholesterol and triglycerides
⢠Infections
⢠Medication interactions